Release Date: 11/01/21 12:17 Summary: Initial Director's Interest Notice - M Rosenstreich Price Sensitive: No Download Document 207.97KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution